Spartacus Acquisition (NN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CorMedix again raises its full-year 2025 pro forma net revenue guidance to a range of $390 to $410 million, and fourth quarter net revenue guidance to a range of $115 to $135 million. In addition, the ...
Zacks Investment Research on MSN
Naspers (NPSNY) Upgraded to Buy: What Does It Mean for the Stock?
Investors might want to bet on Naspers Ltd. (NPSNY), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...
CorMedix again raises its full-year 2025 pro forma net revenue guidance to a range of $390 to $410 million, and fourth quarter net revenue guidance to a range of $115 to $135 million. In addition, the ...
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...
ProShares S&P 500 Dividend Aristocrats ETF's (NOBL) dividend strategy may no longer be effective. Explore six superior ...
Explore vibration measurement technologies, their pros and cons, and applications in engineering and industrial testing.
This study is useful because it challenges the widely accepted notion that muscle stem cell numbers decline with aging, providing novel insights into population heterogeneity and the identification of ...
This inflation calculator uses the change in the Consumer Price Index (CPI) from 1913 to 2025 to estimate the U.S. dollar's buying power and future value.
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback